Evercore ISI Sticks to Its Hold Rating for DENTSPLY SIRONA (XRAY)

In a report released today, Elizabeth Anderson CFA from Evercore ISI maintained a Hold rating on DENTSPLY SIRONA, with a price target of $12.00.

Claim 70% Off TipRanks Premium

• Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
• Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

Anderson CFA covers the Healthcare sector, focusing on stocks such as Henry Schein, Align Tech, and Charles River Labs. According to TipRanks, Anderson CFA has an average return of -1.1% and a 49.67% success rate on recommended stocks.

In addition to Evercore ISI, DENTSPLY SIRONA also received a Hold from TipRanks – OpenAI’s OpenAI Medical – Instruments and Supplies in a report issued today. However, on the same day, TipRanks – Anthropic downgraded DENTSPLY SIRONA (NASDAQ: XRAY) to a Sell.

Based on DENTSPLY SIRONA’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $904 million and a GAAP net loss of $427 million. In comparison, last year the company earned a revenue of $951 million and had a GAAP net loss of $494 million

Based on the recent corporate insider activity of 88 insiders, corporate insider sentiment is neutral on the stock. Last month, Gregory Lucier, a Director at XRAY sold 82,200.00 shares for a total of $915,708.00.